IP Library › Assignment 050565/0300
Patent Assignment
Reel/Frame 050565/0300

Release of Security Interest

Recorded: 2019-09-27 Pages: 55
Assignor
Assignee
REVANCE THERAPEUTICS, INC.
7555 GATEWAY BOULEVARD, NEWARK, CALIFORNIA, 94560
Covered Properties (27)
Multi-Component Biological Transport Systems
Patent: 7,807,780 →
Application: 09/910,432 →
Publication: US 2003/0229034
Multi-Component Biological Transport Systems
Application: 10/591,485 →
Publication: US 2008/0200373
Compositions and Methods for Topical Diagnostic and Therapeutic Transport
Patent: 8,974,774 →
Application: 10/591,486 →
Publication: US 2008/0038203
Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins
Patent: 8,398,997 →
Application: 10/591,732 →
Publication: US 2008/0107690
Multi-Component Biological Transport Systems
Application: 10/793,138 →
Publication: US 2004/0220100
Compositions and methods for topical application and transdermal delivery of botulinum toxins
Patent: 8,404,249 →
Application: 11/072,026 →
Publication: US 2005/0196414
Compositions and Methods for Topical Diagnostic and Therapeutic Transport
Patent: 8,092,788 →
Application: 11/073,307 →
Publication: US 2005/0239705
Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins
Patent: 9,180,081 →
Application: 11/367,642 →
Publication: US 2007/0077259
Compositions and Methods of Topical Application and Transdermal Delivery of Botulinum Toxins with Reduced Non-Toxin Proteins
Patent: 8,568,740 →
Application: 11/560,555 →
Publication: US 2007/0116724
Arginine Heteromers for Topical Administration
Patent: 8,815,954 →
Application: 11/617,551 →
Publication: US 2007/0265233
Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins
Patent: 9,314,416 →
Application: 11/816,602 →
Publication: US 2009/0087457
Transport Molecules Using Reverse Sequence HIV-TAT Polypeptides
Application: 11/954,885 →
Publication: US 2008/0226551
Compositions and Methods of Topical Application and Transdermal Delivery of Botulinum Toxins Stabilized with Polypeptide Fragments Derived from HIV-TAT
Application: 11/955,076 →
Publication: US 2008/0233152
Compositions and Methods of Topical Application and Transdermal Delivery of Botulinum Toxins with Reduced Non-Toxin Proteins
Patent: 8,518,414 →
Application: 12/093,442 →
Publication: US 2009/0163412
Arginine Heteromers for Topical Administration
Patent: 8,628,756 →
Application: 12/159,584 →
Publication: US 2009/0214452
Transport Molecules Using Reverse Sequence HIV-TAT Polypeptides
Application: 12/520,964 →
Publication: US 2010/0093639
Compositions and Methods of Topical Application and Transdermal Delivery of Botulinum Toxins Stabililzed with Polypeptide Fragments Derived from HIV-TAT
Application: 12/520,971 →
Publication: US 2010/0021502
Injectable Botulinum Toxin Formulations
Application: 12/647,677 →
Publication: US 2010/0168023
Compositions and Methods for Treating Hyperpigmentation
Application: 12/647,739 →
Publication: US 2010/0166689
Antimicrobial Peptide, Compositions, and Methods of Use
Patent: 8,623,811 →
Application: 12/669,705 →
Publication: US 2010/0215591
Albumin-Free Botulinum Toxin Formulations
Patent: 9,340,587 →
Application: 12/824,118 →
Publication: US 2010/0330123
Multi-Component Biological Transport Systems
Application: 12/897,188 →
Publication: US 2011/0020229
Methods and Systems for Purifying Non-Complexed Botulinum Neurotoxin
Application: 12/908,647 →
Publication: US 2011/0092682
Device and Method for Topical Application of Therapeutics or Cosmetic Compositions
Application: 12/911,398 →
Publication: US 2011/0106021
Injectable Botulinum Toxin Formulations
Patent: 9,956,435 →
Application: 13/141,935 →
Publication: US 2011/0268765
Compositions and Methods for Treating Hyperpigmentation
Application: 13/141,962 →
Publication: US 2012/0014894
Methods and kits for topical application, removal, and inactivation of therapeutic or cosmetic toxin compositions
Application: 61/430,868 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 14, 2002
From: WAUGH, JACOB; DAKE, MICHAEL
To: ESSENTIA BIOSYSTEMS, INC.
Reel/Frame 012492/0919 →
Assignment of Assignor's Interest Jul 7, 2004
From: WAUGH, JACOB; DAKE, MICHAEL
To: ESSENTIA BIOSYSTEMS, INC.
Reel/Frame 015537/0658 →
Assignment of Assignor's Interest Jul 6, 2005
From: DAKE, MICHAEL D.; WAUGH, JACOB M.
To: ESSENTIA BIOSYTEMS, INC.
Reel/Frame 016755/0031 →
Assignment of Assignor's Interest Dec 13, 2006
From: DAKE, MICHAEL D.; WAUGH, JACOB M.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 018628/0455 →
Assignment of Assignor's Interest Dec 13, 2006
From: DAKE, MICHAEL D.; WAUGH, JACOB M.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 018628/0419 →
Assignment of Assignor's Interest Dec 13, 2006
From: WAUGH, JACOB M.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 018626/0795 →
Assignment of Assignor's Interest Dec 13, 2006
From: DAKE, MICHAEL D.; WAUGH, JACOB M.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 018628/0284 →
Assignment of Assignor's Interest Dec 13, 2006
From: DAKE, MICHAEL D.; WAUGH, JACOB M.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 018628/0598 →
Assignment of Assignor's Interest Dec 13, 2006
From: WAUGH, JACOB M.; DAKE, MICHAEL D.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 018628/0573 →
Assignment of Assignor's Interest Jan 17, 2007
From: WAUGH, JACOB M.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 018768/0065 →
Assignment of Assignor's Interest May 13, 2008
From: WAUGH, JACOB M; LEE, JAE HOON
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 020943/0456 →
Assignment of Assignor's Interest May 13, 2008
From: WAUGH, JACOB M; LEE, JAE HOON
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 020943/0475 →
Assignment of Assignor's Interest Oct 6, 2008
From: DAKE, MICHAEL D.; WAUGH, JACOB M.
To: REVANCE THERAPEUTICS, INC
Reel/Frame 021639/0144 →
Assignment of Assignor's Interest Oct 7, 2008
From: WAUGH, JACOB M.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 021662/0665 →
Assignment of Assignor's Interest Oct 7, 2008
From: WAUGH, JACOB M.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 021662/0548 →
Change of Name Mar 20, 2009
From: ESSENTIA BIOSYSTEMS, INC.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 022431/0053 →
Security Agreement May 29, 2009
From: REVANCE THERAPEUTICS, INC.
To: LEADER VENTURES, LLC
Reel/Frame 022756/0549 →
Assignment of Assignor's Interest Jul 14, 2009
From: WAUGH, JACOB M.; LEE, JAE HOON
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 022949/0795 →
Assignment of Assignor's Interest Jul 14, 2009
From: WAUGH, JACOB M.; LEE, JAE HOON
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 022949/0893 →
Assignment of Assignor's Interest Feb 3, 2010
From: STONE, HONGRAN FAN; WAUGH, JACOB M.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 023889/0346 →
Assignment of Assignor's Interest Feb 18, 2010
From: RUEGG, CURTIS L.; STONE, HONGRAN F.; WAUGH, JACOB M.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 023956/0509 →
Assignment of Assignor's Interest Feb 18, 2010
From: WAUGH, JACOB M.
To: REVANCE THERAPEUTICS, INC.
Reel/Frame 023956/0474 →
Security Agreement May 24, 2010
From: REVANCE THERAPEUTICS, INC.
To: LEADER VENTURES, LLC
Reel/Frame 024432/0317 →
Security Agreement May 24, 2010
From: REVANCE THERAPEUTICS, INC.
To: LEADER VENTURES, LLC
Reel/Frame 024432/0284 →
Security Agreement May 24, 2010
From: REVANCE THERAPEUTICS, INC.
To: LEADER VENTURES, LLC
Reel/Frame 024432/0187 →